Methylglyoxal-induced neurotoxic effects in primary neuronal-like cells transdifferentiated from human mesenchymal stem cells: Impact of low concentrations.
aging
glycotoxins
human mesenchymal stem cells
in vitro human cell-based testing
neurodegeneration
neurotoxicity
Journal
Journal of applied toxicology : JAT
ISSN: 1099-1263
Titre abrégé: J Appl Toxicol
Pays: England
ID NLM: 8109495
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
revised:
12
06
2023
received:
16
05
2023
accepted:
26
06
2023
medline:
10
11
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
In the last decades, advanced glycation end-products (AGEs) have aroused the interest of the scientific community due to the increasing evidence of their involvement in many pathophysiological processes including various neurological disorders and cognitive decline age related. Methylglyoxal (MG) is one of the reactive dicarbonyl precursors of AGEs, mainly generated as a by-product of glycolysis, whose accumulation induces neurotoxicity. In our study, MG cytotoxicity was evaluated employing a human stem cell-derived model, namely, neuron-like cells (hNLCs) transdifferentiated from mesenchymal stem/stromal cells, which served as a source of human based species-specific "healthy" cells. MG increased ROS production and induced the first characteristic apoptotic hallmarks already at low concentrations (≥10 μM), decreased the cell growth (≥5-10 μM) and viability (≥25 μM), altered Glo-1 and Glo-2 enzymes (≥25 μM), and markedly affected the neuronal markers MAP-2 and NSE causing their loss at low MG concentrations (≥10 μM). Morphological alterations started at 100 μM, followed by even more marked effects and cell death after few hours (5 h) from 200 μM MG addition. Substantially, most effects occurred as low as 10 μM, concentration much lower than that reported from previous observations using different in vitro cell-based models (e.g., human neuroblastoma cell lines, primary animal cells, and human iPSCs). Remarkably, this low effective concentration approaches the level range measured in biological samples of pathological subjects. The use of a suitable cellular model, that is, human primary neurons, can provide an additional valuable tool, mimicking better the physiological and biochemical properties of brain cells, in order to evaluate the mechanistic basis of molecular and cellular alterations in CNS.
Substances chimiques
Pyruvaldehyde
722KLD7415
Glycation End Products, Advanced
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1819-1839Informations de copyright
© 2023 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
Références
Allaman, I., Bélanger, M., & Magistretti, P. J. (2015). Methylglyoxal, the dark side of glycolysis. Frontiers in Neuroscience, 9, 23. https://doi.org/10.3389/fnins.2015.00023
Angeloni, C., Malaguti, M., Rizzo, B., Barbalace, M. C., Fabbri, D., & Hrelia, S. (2015). Neuroprotective effect of sulforaphane against methylglyoxal cytotoxicity. Chemical Research in Toxicology, 28(6), 1234-1245. https://doi.org/10.1021/acs.chemrestox.5b00067
Angeloni, C., Zambonin, L., & Hrelia, S. (2014). Role of methylglyoxal in Alzheimer's disease. BioMed Research International, 2014, 238485. https://doi.org/10.1155/2014/238485
Bair, W. B. 3rd, Cabello, C. M., Uchida, K., Bause, A. S., & Wondraka, G. T. (2010). GLO1 overexpression in human malignant melanoma. Melanoma Research, 20(2), 85-96. https://doi.org/10.1097/CMR.0b013e3283364903
Beeri, M. S., Moshier, E., Schmeidler, J., Godbold, J., Uribarri, J., Reddy, S., Sano, M., Grossman, H. T., Cai, W., Vlassara, H., & Silverman, J. M. (2011). Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mechanisms of Ageing and Development, 132(11-12), 583-587. https://doi.org/10.1016/j.mad.2011.10.007
Bélanger, M., Yang, J., Petit, J. M., Laroche, T., Magistretti, P. J., & Allaman, I. (2011). Role of the glyoxalase system in astrocyte-mediated neuroprotection. Neuroscience, 31(50), 18338-18352. https://doi.org/10.1523/JNEUROSCI.1249-11.2011
Bhat, L. R., Vedantham, S., Krishnan, U. M., & Rayappan, J. B. B. (2019). Methylglyoxal - An emerging biomarker for diabetes mellitus diagnosis and its detection methods. Biosensors & Bioelectronics, 133, 107-124. https://doi.org/10.1016/j.bios.2019.03.010
Bhat, W. F., Bhat, S. A., Khaki, P. S. S., & Bano, B. (2015). Employing in vitro analysis to test the potency of methylglyoxal in inducing the formation of amyloid-like aggregates of caprine brain cystatin. Amino Acids, 47(1), 135-146. https://doi.org/10.1007/s00726-014-1848-2
Bosch, J., Houben, A. P., Radke, T. F., Stapelkamp, D., Bünemann, E., Balan, P., Buchheiser, A., Liedtke, S., & Kögler, G. (2012). Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: Are cord-derived cells true mesenchymal stromal cells? Stem Cells and Development, 21(11), 1977-1988. https://doi.org/10.1089/scd.2011.0414
Buzanska, L., Sypecka, J., Nerini-Molteni, S., Compagnoni, A., Hogberg, H. T., del Torchio, R., Domanska-Janik, K., Zimmer, J., & Coecke, S. (2009). A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells, 27(10), 2591-2601. https://doi.org/10.1002/stem.179
Chan, W. H., & Wu, H. J. (2008). Methylglyoxal and high glucose co-treatment induces apoptosis or necrosis in human umbilical vein endothelial cells. Journal of Cellular Biochemistry, 103(4), 1144-1157. https://doi.org/10.1002/jcb.21489
Chen, Y. J., Huang, X. B., Li, Z. X., Yin, L. L., Chen, W. Q., & Li, L. (2010). Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. European Journal of Pharmacology, 645(1-3), 1-8. https://doi.org/10.1016/j.ejphar.2010.06.034
Coccini, T., De Simone, U., Roccio, M., Croce, S., Lenta, E., Zecca, M., Spinillo, A., & Avanzini, M. A. (2019). In vitro toxicity screening of magnetite nanoparticles by applying mesenchymal stem cells derived from human umbilical cord lining. Journal of Applied Toxicology, 39(9), 1320-1336. https://doi.org/10.1002/jat.3819
Coccini, T., Pignatti, P., Spinillo, A., & De Simone, U. (2020). Developmental neurotoxicity screening for nanoparticles using neuronlike cells of human umbilical cord mesenchymal stem cells: Example with magnetite nanoparticles. Nanomaterials (Basel), 10, 1-28. https://doi.org/10.3390/nano10081607
Coccini, T., Spinillo, A., Roccio, M., Lenta, E., Valsecchi, C., & De Simone, U. (2022). Human umbilical cord mesenchymal stem cell-based in vitro model for neurotoxicity testing. Current Protocols, 2(4), e423. https://doi.org/10.1002/cpz1.423
Conti Mazza, M., Shuck, S. C., Lin, J., Moxley, M. A., Termini, J., Cookson, M. R., & Wilson, M. A. (2022). DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons. Journal of Neurochemistry, 162(3), 245-261. https://doi.org/10.1111/jnc.15656
Cortés-Medina, L. V., Pasantes-Morales, H., Aguilera-Castrejon, A., Picones, A., Lara-Figueroa, C. O., Luis, E., Montesinos, J. J., Cortés-Morales, V. A., de la Rosa Ruiz, M. P., Hernández-Estévez, E., Bonifaz, L. C., Alvarez-Perez, M. A., & Ramos-Mandujano, G. (2019). Neuronal transdifferentiation potential of human mesenchymal stem cells from neonatal and adult sources by a small molecule cocktail. Stem Cells International, 2019, 7627148. https://doi.org/10.1155/2019/7627148
Currais, A., & Maher, P. (2012). Functional consequences of age-dependent changes in glutathione status in the brain. Antioxidants & Redox Signaling, 19(8), 813-822. https://doi.org/10.1089/ars.2012.4996
Czarnecka, J., Porowiǹska, D., Bajek, A., Hołysz, M., & Roszek, K. (2017). Neurogenic differentiation of mesenchymal stem cells induces alterations in extracellular nucleotides metabolism. Journal of Cellular Biochemistry, 118(3), 478-486. https://doi.org/10.1002/jcb.25664
Dafre, A. L., Goldberg, J., Wang, T., Spiegel, D. A., & Maher, P. (2015). Methylglyoxal, the foe and friend of glyoxalase and Trx/TrxR systems in HT22 nerve cells. Free Radical Biology & Medicine, 89, 8-19. https://doi.org/10.1016/j.freeradbiomed.2015.07.005
Dafre, A. L., Schmitz, A. E., & Maher, P. (2017). Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells. Free Radical Biology & Medicine, 108, 270-279. https://doi.org/10.1016/j.freeradbiomed.2017.03.028
de Almeida, G. R. L., Szczepanik, J. C., Selhorst, I., Cunha, M. P., & Dafre, A. L. (2023). The expanding impact of methylglyoxal on behavior-related disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 120, 110635. https://doi.org/10.1016/j.pnpbp.2022.110635
de Arriba, S. G., Stuchbury, G., Yarin, J., Burnell, J., Loske, C., & Münch, G. (2007). Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiology of Aging, 28(7), 1044-1050. https://doi.org/10.1016/j.neurobiolaging.2006.05.007
de Oliveira, M. R., Custódio de Souza, I. C., & Bittencourt Brasil, F. (2021). Promotion of mitochondrial protection by emodin in methylglyoxal-treated human neuroblastoma SH-SY5Y cells: Involvement of the AMPK/Nrf2/HO-1 Axis. Neurotoxicity Research, 39(2), 292-304. https://doi.org/10.1007/s12640-020-00287-w
de Oliveira, M. R., da Costa, F. G., Peres, A., & Bosco, S. M. D. (2018). Carnosic acid suppresses the H2O2-induced mitochondria-related bioenergetics disturbances and redox impairment in SH-SY5Y cells: Role for Nrf2. Molecular Neurobiology, 55(2), 968-979. https://doi.org/10.1007/s12035-016-0372-7
De Simone, U., Caloni, F., Gribaldo, L., & Coccini, T. (2017). Human co-culture model of neurons and astrocytes to test acute cytotoxicity of neurotoxic compounds. International Journal of Toxicology, 36(6), 463-477. https://doi.org/10.1177/1091581817739428
De Simone, U., Spinillo, A., Caloni, F., Gribaldo, L., & Coccini, T. (2020). Neuron-like cells generated from human umbilical cord lining derived mesenchymal stem cells as a new in vitro model for neuronal toxicity screening: Using magnetite nanoparticles as an example. International Journal of Molecular Sciences, 21(1), 271. https://doi.org/10.3390/ijms21010271
di Loreto, S., Caracciolo, V., Colafarina, S., Sebastiani, P., Gasbarri, A., & Amicarelli, F. (2004). Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells. Brain Research, 1006(2), 157-167. https://doi.org/10.1016/j.brainres.2004.01.066
di Loreto, S., Zimmitti, V., Sebastiani, P., Cervelli, C., Falone, S., & Amicarelli, F. (2008). Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons. International Journal of Biochemistry & Cell Biology, 40(2), 245-257. https://doi.org/10.1016/j.biocel.2007.07.019
Dias, V., Junn, E., & Mouradian, M. M. (2013). The role of oxidative stress in Parkinson's disease. Journal of Parkinson's Disease, 3(4), 461-491. https://doi.org/10.3233/JPD-130230
Dominici, M., le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. https://doi.org/10.1080/14653240600855905
Dringen, R. (2000). Metabolism and functions of glutathione in brain. Progress in Neurobiology, 62(6), 649-671. https://doi.org/10.1016/s0301-0082(99)00060-x
Du, J., Suzuki, H., Nagase, F., Akhand, A. A., Yokoyama, T., Miyata, T., Kurokawa, K., & Nakashima, I. (2000). Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. Journal of Cellular Biochemistry, 77(2), 333-344. https://doi.org/10.1002/(sici)1097-4644(20000501)77:2<333::aid-jcb15>3.0.co;2-q
Fan, P., Wang, Y., Xu, M., Han, X., & Liu, Y. (2022). The application of brain organoids in assessing neural toxicity. Frontier of Molecular Neuroscience, 15, 799397. https://doi.org/10.3389/fnmol.2022.799397
Fan, X., Sell, D. R., Hao, C., Liu, S., Wang, B., Wesson, D. W., Siedlak, S., Zhu, X., Kavanagh, T. J., Harrison, F. E., & Monnier, V. M. (2020). Vitamin C is a source of oxoaldehyde and glycative stress in age-related cataract and neurodegenerative diseases. Aging Cell, 19(7), e13176. https://doi.org/10.1111/acel.13176
Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 9(6), 425-434. https://doi.org/10.1016/j.ccr.2006.04.023
Frandsen, J., & Narayanasamy, P. (2017). Flavonoid enhances the glyoxalase pathway in cerebellar neurons to retain cellular functions. Scientific Reports, 7(1), 5126. https://doi.org/10.1038/s41598-017-05287-z
Frandsen, J. R., & Narayanasamy, P. (2018). Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway. Redox Biology, 14, 465-473. https://doi.org/10.1016/j.redox.2017.10.015
Haddad, M., Perrotte, M., Khedher, M. R. B., Demongin, C., Lepage, A., Fülöp, T., & Ramassamy, C. (2019). Methylglyoxal and glyoxal as potential peripheral markers for MCI diagnosis and their effects on the expression of neurotrophic, inflammatory and neurodegenerative factors in neurons and in neuronal derived-extracellular vesicles. International Journal of Molecular Sciences, 20(19), 4906. https://doi.org/10.3390/ijms20194906
Haik, G. M. Jr., Lo, T. W., & Thornalley, P. J. (1994). Methylglyoxal concentration and glyoxalase activities in the human lens. Experimental Eye Research, 59(4), 497-500. https://doi.org/10.1006/exer.1994.1135
Han, L. P., Davison, L. M., & vander Jagt, D. L. (1976). Purification and kinetic study of glyoxalase-I from rat liver, erythrocytes, brain and kidney. Biochimica et Biophysica Acta, 445(2), 486-499. https://doi.org/10.1016/0005-2744(76)90102-9
Han, Y., Randell, E., Vasdev, S., Gill, V., Gadag, V., Newhook, L. A., Grant, M., & Hagerty, D. (2007). Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Molecular and Cellular Biochemistry, 305(1-2), 123-131. https://doi.org/10.1007/s11010-007-9535-1
Hansen, F., de Souza, D. F., Silveira, S. L., Hoefel, A. L., Fontoura, J. B., Tramontina, A. C., Bobermin, L. D., Leite, M. C., Perry, M. L. S., & Gonçalves, C. A. (2012). Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells. Metabolic Brain Disease, 27(4), 531-539. https://doi.org/10.1007/s11011-012-9329-3
Hanssen, N. M. J., Westerink, J., Scheijen, J. L. J. M., van der Graaf, Y., Stehouwer, C. D. A., Schalkwijk, C. G., & SMART Study Group. (2018). Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with Type 2 diabetes. Diabetes Care, 41, 1689-1695. https://doi.org/10.2337/dc18-0159
Hara, T., Toyoshima, M., Hisano, Y., Balan, S., Iwayama, Y., Aono, H., Futamura, Y., Osada, H., Owada, Y., & Yoshikawa, T. (2021). Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons. Translational Psychiatry, 11(1), 275. https://doi.org/10.1038/s41398-021-01392-w
He, Y., Yang, Z., Pi, J., Cai, T., Xia, Y., Cao, X., & Liu, J. (2022). EGCG attenuates the neurotoxicity of methylglyoxal via regulating MAPK and the downstream signalling pathways and inhibiting advanced glycation end products formation. Food Chemistry, 384, 132358. https://doi.org/10.1016/j.foodchem.2022.132358
Hernández, R., Jiménez-Luna, C., Perales-Adán, J., Perazzoli, G., Melguizo, C., & Prados, J. (2020). Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders. Biomolecules & Therapeutics, 28(1), 34-44. https://doi.org/10.4062/biomolther.2019.065
Hsieh, M. S., & Chan, W. H. (2009). Impact of methylglyoxal and high glucose co-treatment on human mononuclear cells. International Journal of Molecular Sciences, 10(4), 1445-1464. https://doi.org/10.3390/ijms10041445
Huang, S. M., Chuang, H. C., Wu, C. H., & Yen, G. C. (2008). Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells. Molecular Nutrition & Food Research, 52(8), 940-949. https://doi.org/10.1002/mnfr.200700360
Jan, C. R., Chen, C. H., Wang, S. C., & Kuo, S. Y. (2005). Effect of methylglyoxal on intracellular calcium levels and viability in renal tubular cells. Cellular Signalling, 17(7), 847-855. https://doi.org/10.1016/j.cellsig.2004.11.007
Jang, J. H., Kim, E. A., Park, H. J., Sung, E. G., Song, I. H., Kim, J. Y., Woo, C. H., Doh, K. O., Kim, K. H., & Lee, T. J. (2017). Methylglyoxal-induced apoptosis is dependent on the suppression of c-FLIPL expression via down-regulation of p65 in endothelial cells. Journal of Cellular and Molecular Medicine, 21(11), 2720-2731. https://doi.org/10.1111/jcmm.13188
Jensen, T. M., Vistisen, D., Fleming, T., Nawroth, P. P., Rossing, P., Jørgensen, M. E., Lauritzen, T., Sandbaek, A., & Witte, D. R. (2016). Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus. Diabetic Medicine, 33(12), 1625-1631. https://doi.org/10.1111/dme.13201
Jiang, B., Le, L., Liu, H., Xu, L., He, C., Hu, K., Peng, Y., & Xiao, P. (2016). Marein protects against methylglyoxal-induced apoptosis by activating the AMPK pathway in PC12 cells. Free Radical Research, 50(11), 1173-1187. https://doi.org/10.1080/10715762.2016.1222374
Jorfi, M., D'Avanzo, C., Kim, D. Y., & Irimia, D. (2018). Three-dimensional models of the human brain development and diseases. Advanced Healthcare Materials, 7(1), 1-36. https://doi.org/10.1002/adhm.201700723
Kalapos, M. P. (2008). The tandem of free radicals and methylglyoxal. Chemico-Biological Interactions, 171(3), 251-271. https://doi.org/10.1016/j.cbi.2007.11.009
Kalapos, M. P. (2013). Where does plasma methylglyoxal originate from? Diabetes Research and Clinical Practice, 99(3), 260-271. https://doi.org/10.1016/j.diabres.2012.11.003
Kang, P. J., Zheng, J., Lee, G., Son, D., Kim, I. Y., Song, G., Park, G., & You, S. (2019). Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control. Metabolic Engineering, 53, 35-47. https://doi.org/10.1016/j.ymben.2019.02.003
Kashyap, M. P., Kumar, V., Singh, A. K., Tripathi, V. K., Jahan, S., Pandey, A., Srivastava, R. K., Khanna, V. K., & Pant, A. B. (2015). Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity. Molecular Neurobiology, 51, 791-807. https://doi.org/10.1007/s12035-014-8716-7
Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z., Miyata, T., & Tashiro, K. (1999). Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. Journal of Neuroscience Research, 57(2), 280-289. https://doi.org/10.1002/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U
Kil, K., Choi, M. Y., & Park, K. H. (2016). In vitro differentiation of human Wharton's jelly derived mesenchymal stem cells into auditory hair cells and neurons. Journal of International Advanced Otology, 12, 37-42. https://doi.org/10.5152/iao.2016.1190
Kim, T. W., Che, J. H., & Yun, J. W. (2019). Use of stem cells as alternative methods to animal experimentation in predictive toxicology. Regulatory Toxicology and Pharmacology, 105, 15-29. https://doi.org/10.1016/j.yrtph.2019.03.016
Ko, S. Y., Ko, H. A., Chu, K. H., Shieh, T. M., Chi, T. C., Chen, H. I., Chang, S. S., & Chang, S. S. (2015). The possible mechanism of advanced glycation end products (AGEs) for Alzheimer's disease. PLoS ONE, 10(11), e0143345. https://doi.org/10.1371/journal.pone.0143345
Kold-Christensen, R., & Johannsen, M. (2020). Methylglyoxal metabolism and aging-related disease: Moving from correlation toward causation. Trends in Endocrinology and Metabolism, 31(2), 81-92. https://doi.org/10.1016/j.tem.2019.10.003
Kong, X., Ma, M., Huang, K., Qin, L., Zhang, H., Yang, Z., Li, X., & Su, Q. (2014). Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2. Journal of Diabetes, 6(6), 535-540. https://doi.org/10.1111/1753-0407.12160
Kuhla, B., Luth, H. J., Haferburg, D., Boeck, K., Arendt, T., & Munch, G. (2005). Methylglyoxal, glyoxal, and their detoxifi cation in Alzheimer's disease. Annals of the new York Academy of Sciences, 1043, 211-216. https://doi.org/10.1196/annals.1333.026
Kuhla, B., Lüth, H. J., Haferburg, D., Weick, M., Reichenbach, A., Arendt, T., & Münch, G. (2006). Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. Journal of Neuroscience Research, 83(8), 1591-1600. https://doi.org/10.1002/jnr.20838
Lai, S. W. T., Lopez Gonzalez, E. D. J., Zoukari, T., Ki, P., & Shuck, S. C. (2022). Methylglyoxal and its adducts: induction, repair, and association with disease. Chemical Research in Toxicology, 35(10), 1720-1746. https://doi.org/10.1021/acs.chemrestox.2c00160
Leone, A., Nigro, C., Nicolò, A., Prevenzano, I., Formisano, P., Beguinot, F., & Miele, C. (2021). The dual-role of methylglyoxal in tumor progression-Novel therapeutic approaches. Frontiers in Oncology, 11, 645686. https://doi.org/10.3389/fonc.2021.645686
Li, G., Chang, M., Jiang, H., Xie, H., Dong, Z., & Hu, L. (2011). Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells. Cell Biochemistry and Function, 29(1), 30-35. https://doi.org/10.1002/cbf.1714
Li, J., Liu, D., Sun, L., Lu, Y., & Zhang, Z. (2012). Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective. Journal of the Neurological Sciences, 317(1-2), 1-5. https://doi.org/10.1016/j.jns.2012.02.018
Li, X. H., Du, L. L., Cheng, X. S., Jiang, X., Zhang, Y., Lv, B. L., Liu, R., Wang, J. Z., & Zhou, X. W. (2013). Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death & Disease, 4(6), e673. https://doi.org/10.1038/cddis.2013.180
Lo, T. W., Selwood, T., & Thornalley, P. J. (1994). The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochemical Pharmacology, 48(10), 1865-1870. https://doi.org/10.1016/0006-2952(94)90584-3
Maessen, D. E., Hanssen, N. M., Lips, M. A., Scheijen, J. L., Willems van Dijk, K., Pijl, H., Stehouwer, C. D., & Schalkwijk, C. G. (2016). Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes. Diabetologia, 59, 2013-2017. https://doi.org/10.1007/s00125-016-4009-1
Maessen, D. E., Stehouwer, C. D., & Schalkwijk, C. G. (2015). The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clinical Science, 128, 839-861. https://doi.org/10.1042/CS20140683
Manza, P., Wiers, C. E., Shokri-Kojori, E., Kroll, D., Feldman, D., Schwandt, M., Wang, G. J., Tomasi, D., & Volkow, N. D. (2020). Brain network segregation and glucose energy utilization: Relevance for age-related differences in cognitive function. Cerebral Cortex, 30(11), 5930-5942. https://doi.org/10.1093/cercor/bhaa167
Masjosthusmann, S., Barenys, M., el-Gamal, M., Geerts, L., Gerosa, L., Gorreja, A., Kühne, B., Marchetti, N., Tigges, J., Viviani, B., Witters, H., & Fritsche, E. (2018). Literature review and appraisal on alternative neurotoxicity testing methods. EFSA, External Scientific Report, 15(4), 1-125. https://doi.org/10.2903/sp.efsa.2018.EN-1410
McLellan, A. C., & Thornalley, P. J. (1989). Glyoxalase activity in human red blood cells fractioned by age. Mechanisms of Ageing and Development, 48(1), 63-71. https://doi.org/10.1016/0047-6374(89)90026-2
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994). Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clinical Science, 87(1), 21-29. https://doi.org/10.1042/cs0870021
Nigro, C., Leone, A., Raciti, G. A., Longo, M., Mirra, P., Formisano, P., Beguinot, F., & Miele, C. (2017). Methylglyoxal-glyoxalase 1 balance: The root of vascular damage. International Journal of Molecular Sciences, 18(1), 188. https://doi.org/10.3390/ijms18010188
Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., & Maeda, K. (1999). Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochemical and Biophysical Research Communications, 256(1), 89-93. https://doi.org/10.1006/bbrc.1999.0221
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014). Role of advanced glycation end products in cellular signalling. Redox Biology, 2, 411-429. https://doi.org/10.1016/j.redox.2013.12.016
Piazza, M., Hanssen, N. M. J., Persson, F., Scheijen, J. L., van de Waarenburg, M. P. H., van Greevenbroek, M. M. J., Rossing, P., Hovind, P., Stehouwer, C. D. A., Parving, H. H., & Schalkwijk, C. G. (2021). Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study. Diabetic Medicine: Journal of the British Diabetic Association, 38(9), e14405. https://doi.org/10.1111/dme.14405
Pisoschi, A. M., & Pop, A. (2015). The role of antioxidants in the chemistry of oxidative stress: A review. European Journal of Medicinal Chemistry, 97, 55-74. https://doi.org/10.1016/j.ejmech.2015.04.040
Popelová, A., Kákonová, A., Hrubá, L., Kuneš, J., Maletínská, L., & Železná, B. (2018). Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: An in vitro study using SH-SY5Y cells. Physiological Research/Academia Scientiarum Bohemoslovaca, 67(2), 339-346. https://doi.org/10.33549/physiolres.933761
Qi, L., Gao, R., Chen, Z., Lin, D., Liu, Z., Wang, L., Lin, L., Liu, X., Liu, X., & Liu, L. (2022). Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells. Neurotoxicology, 92, 166-179. https://doi.org/10.1016/j.neuro.2022.08.007
Rabbani, N. (2022). Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes. Clinical Science, 136(11), 819-824. https://doi.org/10.1042/CS20220099
Rabbani, N., & Thornalley, P. J. (2014). Dicarbonyl proteome and genome damage in metabolic and vascular disease. Biochemical Society Transactions, 42(2), 425-432. https://doi.org/10.1042/BST20140018
Rabbani, N., & Thornalley, P. J. (2015). Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease. Biochemical and Biophysical Research Communications, 458(2), 221-226. https://doi.org/10.1016/j.bbrc.2015.01.140
Rabbani, N., Xue, M., & Thornalley, P. J. (2016). Methylglyoxal-induced dicarbonyl stress in aging and disease: First steps towards glyoxalase 1-based treatments. Clinical Science, 130(19), 1677-1696. https://doi.org/10.1042/CS20160025
Radu, B. M., Dumitrescu, D. I., Mustaciosu, C. C., & Radu, M. (2012). Dual effect of methylglyoxal on the intracellular Ca2+ signalling and neurite outgrowth in mouse sensory neurons. Cellular and Molecular Neurobiology, 32(6), 1047-1057. https://doi.org/10.1007/s10571-012-9823-5
Sakamoto, H., Mashima, T., Sato, S., Hashimoto, Y., Yamori, T., & Tsuruo, T. (2001). Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells. Clinical Cancer Research, 7, 2513-2518.
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020). Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiological Reviews, 100(1), 407-461. https://doi.org/10.1152/physrev.00001.2019
Scheijen, J. L., & Schalkwijk, C. G. (2014). Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: Evaluation of blood specimen. Clinical Chemistry and Laboratory Medicine, 52(1), 85-91. https://doi.org/10.1515/cclm-2012-0878
Schmitz, A. E., de Souza, L. F., dos Santos, B., Maher, P., Lopes, F. M., Londero, G. F., Klamt, F., & Dafre, A. L. (2017). Methylglyoxal-induced protection response and toxicity: Role of glutathione reductase and thioredoxin systems. Neurotoxicity Research, 32(3), 340-350. https://doi.org/10.1007/s12640-017-9738-5
Scirè, A., Cianfruglia, L., Minnelli, C., Romaldi, B., Laudadio, E., Galeazzi, R., Antognelli, C., & Armeni, T. (2022). Glyoxalase 2: Towards a broader view of the second player of the glyoxalase system. Antioxidants (Basel, Switzerland), 11(11), 2131. https://doi.org/10.3390/antiox11112131
Shahbazi, A., Safa, M., Alikarami, F., Kargozar, S., Asadi, M. H., Joghataei, M. T., & Soleimani, M. (2016). Rapid induction of neural differentiation in human umbilical cord matrix mesenchymal stem cells by camp-elevating agents. International Journal of Molecular and Cellular Medicine, 5(3), 167-177.
Sharma-Luthra, R., & Kale, R. K. (1994). Age related changes in the activity of the glyoxalase system. Mechanisms of Ageing and Development, 73(1), 39-45. https://doi.org/10.1016/0047-6374(94)90036-1
Shi, Y., Nan, C., Yan, Z., Liu, L., Zhou, J., Zhao, Z., & Li, D. (2018). Synaptic plasticity of human umbilical cord mesenchymal stem cell differentiating into neuron-like cells in vitro induced by edaravone. Stem Cells International, 2018, 5304279. https://doi.org/10.1155/2018/5304279
Singh, A. K., & Kashyap, M. P. (2016). An overview on human umbilical cord blood stem cell-based alternative in vitro models for developmental neurotoxicity assessment. Molecular Neurobiology, 53, 3216-3226. https://doi.org/10.1007/s12035-015-9202-6
Singh, S., Srivastava, A., Kumar, V., Pandey, A., Kumar, D., Rajpurohit, C. S., Khanna, V. K., Yadav, S., & Pant, A. B. (2016). Stem cells in neurotoxicology/developmental neurotoxicology: Current scenario and future prospects. Molecular Neurobiology, 53(10), 6938-6949. https://doi.org/10.1007/s12035-015-9615-2
Srikanth, V., Westcott, B., Forbes, J., Phan, T. G., Beare, R., Venn, A., Pearson, S., Greenaway, T., Parameswaran, V., & Münch, G. (2013). Methylglyoxal, cognitive function and cerebral atrophy in older people. Journals of Gerontology, 68(1), 68-73. https://doi.org/10.1093/gerona/gls100
Strom, A., Strassburger, K., Schmuck, M., Shevalye, H., Davidson, E., Zivehe, F., Bönhof, G., Reimer, R., Belgardt, B. F., Fleming, T., Biermann, B., Burkart, V., Müssig, K., Szendroedi, J., Yorek, M. A., Fritsche, E., Nawroth, P. P., Roden, M., Ziegler, D., & GDS Group. (2021). Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models. Molecular Metabolism, 43, 101114. https://doi.org/10.1016/j.molmet.2020.101114
Suh, K. S., Chon, S., Jung, W. W., & Choi, E. M. (2022). Protective effects of sciadopitysin against methylglyoxal-induced degeneration in neuronal SK-N-MC cells. Journal of Applied Toxicology, 42(2), 274-284. https://doi.org/10.1002/jat.4211
Suma, R. N., & Mohanan, P. V. (2015). Stem cells, a new generation model for predictive nanotoxicological assessment. Current Drug Metabolism, 16, 932-939. https://doi.org/10.2174/1389200216666151015113720
Szczepanik, J. C., de Almeida, G. R. L., Cunha, M. P., & Dafre, A. L. (2020). Repeated methylglyoxal treatment depletes dopamine in the prefrontal cortex, and causes memory impairment and depressive-like behavior in mice. Neurotoxicity Research, 45(2), 354-370. https://doi.org/10.1007/s11064-019-02921-2
Tajes, M., Eraso-Pichot, A., Rubio-Moscardo, F., Guivernau, B., Bosch-Morato, M., Valls-Comamala, V., & Munoz, F. J. (2014). Methylglyoxal reduces mitochondrial potential and activates Bax and caspase-3 in neurons: Implications for Alzheimer's disease. Neuroscience Letters, 580, 78-82. https://doi.org/10.1016/j.neulet.2014.07.047
Thornalley, P. J. (2008). Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabolism and Drug Interactions, 23(1-2), 125-150. https://doi.org/10.1515/dmdi.2008.23.1-2.125
Tseng, Y. T., Tsai, Y. H., Fülöp, F., Chang, F. R., & Lo, Y. C. (2019). 2-iodo-4′-Methoxychalcone attenuates methylglyoxal-induced neurotoxicity by activation of GLP-1 receptor and enhancement of neurotrophic signal, antioxidant defense and glyoxalase pathway. Molecules, 24(12), 2249. https://doi.org/10.3390/molecules24122249
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022). Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cell, 11(8), 1312. https://doi.org/10.3390/cells11081312
van Heijst, J. W., Niessen, H. W., Musters, R. J., Hinsbergh, V. W., Hoekman, K., & Schalkwijk, C. G. (2006). Argpyrimidine modified heat shock protein 27 in human non-small cell lung cancer: A possible mechanism for evasion of apoptosis. Cancer Letters, 241, 309-319. https://doi.org/10.1016/j.canlet.2005.10.042
Wang, G., Wang, Y., Yang, Q., Xu, C., Zheng, Y., Wang, L., Wu, J., Zeng, M., & Luo, M. (2022). Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo. Cell Death & Disease, 13(1), 29. https://doi.org/10.1038/s41419-021-04478-x
Wang, Z., Wang, S. N., Xu, T. Y., Miao, Z. W., Su, D. F., & Miao, C. Y. (2017). Organoid technology for brain and therapeutics research. CNS Neuroscience & Therapeutics, 23(10), 771-778. https://doi.org/10.1111/cns.12754
Wong, A., Lüth, H. J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T., & Münch, G. (2001). Advanced glycation end-products co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Research, 920(1-2), 32-40. https://doi.org/10.1016/s0006-8993(01)02872-4
Xie, B., Lin, F., Peng, L., Ullah, K., Wu, H., Qing, H., & Deng, Y. (2014). Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells. Acta Biochimica et Biophysica Sinica, 46(11), 950-956. https://doi.org/10.1093/abbs/gmu094
Yang, Z., Zhang, W., Lu, H., & Cai, S. (2022). Methylglyoxal in the brain: From glycolytic metabolite to signalling molecule. Molecules, 27(22), 7905. https://doi.org/10.3390/molecules27227905
Yin, X., Mead, B. E., Helia, S., Langer, R., Karp, J. M., & Levy, O. (2017). Stem cell organoid engineering. Cell Stem Cell, 18(1), 25-38. https://doi.org/10.1016/j.stem.2015.12.005
Yoo, H. J., Hong, C. O., Ha, S. K., & Lee, K. W. (2020). Chebulic acid prevents methylglyoxal-induced mitochondrial dysfunction in INS-1 pancreatic β-cells. Antioxidants, 9(9), 771. https://doi.org/10.3390/antiox9090771
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019). Stem cells: Past, present, and future. Stem Cell Research & Therapy, 10(1), 68. https://doi.org/10.1186/s13287-019-1165-5
Zheng, L., van Dongen, K. C. W., Bakker, W., Miro Estruch, I., & Rietjens, I. M. C. M. (2022). The influence of intracellular glutathione levels on the induction of Nrf2-mediated gene expression by α-dicarbonyl precursors of advanced glycation end products. Nutrients, 14(7), 1364. https://doi.org/10.3390/nu14071364
Zychowicz, M., Dziedzicka, D., Mehn, D., Kozlowska, H., Kinsner-Ovaskainen, A., Stępień, P. P., Rossi, F., & Buzanska, L. (2014). Developmental stage dependent neural stem cells sensitivity to methylmercury chloride on different biofunctional surfaces. Toxicology in Vitro, 28(1), 76-87. https://doi.org/10.1016/j.tiv.2013.06.023